Search

Most 3D spine reconstruction methods require X-ray images as input, which usually leads to high cost and radiation damage. Therefore, these methods are hardly ever applied to large scale scoliosis screening or spine pose monitoring during treatment. We propose a novel, low-cost, easy-to-operate and none-radioactive 3D spine model reconstruction method, which is based on human back surface information without requiring X-ray images as input. Our method fits a pre-built Spine Priors Model (SPrM) to human back surface information and reconstructs the main part of spine with 17 vertebrae: lumbar vertebrae L1–L5 and thoracic vertebrae T1–T12. The Spine Priors Model is constructed according to human spine priors, including Statistical Spine Shape Model (SSSM), Spine Pose Model (SPM) and Spine Biomechanical Simplified Model (SBSM). The spine-related information on back surface, including back surface spinous curve and local symmetry nearby spinous curve is extracted from the RGBD images of human back surface. We formulate the spine optimization constraints from spine-related feature on back surface and spine priors, then optimize the spine model by gradient descent to get the optimal personalized shape parameters and pose parameters of the Spine Priors Model (SPrM). We assess our reconstruction by scoliosis Cobb angle error, and the result is comparable to current X-ray based methods.

In clinical practice, we noticed that triple negative breast cancer (TNBC) patients had higher shear-wave elasticity (SWE) stiffness than non-TNBC patients and a higher α-SMA expression was found in TNBC tissues than the non-TNBC tissues. Moreover, SWE stiffness also shows a clear correlation to neoadjuvant response efficiency. To elaborate this phenomenon, TNBC cell membrane-modified polylactide acid-glycolic acid (PLGA) nanoparticle was fabricated to specifically deliver artesunate to regulate SWE stiffness through inhibiting CAFs functional status. As tested in MDA-MB-231 and E0771 orthotopic tumor models, CAFs functional status inhibited by 231M-ARS@PLGA nanoparticles (231M-AP NPs) had reduced the SWE stiffness as well as attenuated hypoxia of tumor as tumor soil loosening agent which amplified the antitumor effects of paclitaxel and PD1 inhibitor. Single-cell sequencing indicated that the two main CAFs (extracellular matrix and wound healing CAFs) that produces extracellular matrix could influence the tumor SWE stiffness as well as the antitumor effect of drugs. Further, biomimetic nanoparticles inhibited CAFs function could attenuate tumor hypoxia by increasing proportion of inflammatory blood vessels and oxygen transport capacity. Therefore, our finding is fundamental for understanding the role of CAFs on affecting SWE stiffness and drugs antitumor effects, which can be further implied in the potential clinical theranostic predicting in neoadjuvant therapy efficacy through non-invasive analyzing of SWE imaging.